Navigation Links
Queen's University Belfast lung injury study could save lives in critically ill
Date:10/13/2010

Researchers at Queen's University Belfast are investigating a potential new treatment for lung disease that could save many lives each year.

The research team is studying how statins, drugs which are commonly used to treat high cholesterol, can be used to treat lung disease.

There is currently no effective treatment for acute lung injury. The team hopes the work could boost survival rates for those who become critically ill and suffer lung failure after incidents such as road traffic accidents or severe infections.

Leading the research is Professor Danny McAuley from Queen's Centre for Infection and Immunity. He said: "When people are critically ill their lungs can fail. This is termed 'acute lung injury' and means that the lungs fill with water instead of air. Breathing becomes difficult and a ventilator is needed to take over.

"Statins have the potential to improve lung injury by reducing inflammation in the lung, reversing the damage and therefore decreasing the amount of water in the lungs. This helps fight infection."

The team includes Queen's researchers, Dr Celia O'Kane and Professor Cliff Taggart, along with Professor John Laffey from National University Ireland, Galway.

The research has the potential to free up healthcare resources and allow more people to return to the workplace sooner following spells in hospital.

Professor McAuley added: "There may be up to 45,000 cases of acute lung injury each year in the UK and Ireland and up to 22,000 deaths. Only around half of those who survive are able to return to work 12 months after discharge from hospital. After recovery from lung injury, patients can go on to experience a poorer quality of life and many are unable to look after themselves.

"But this treatment has the potential to reduce the impact of acute lung injury and the time patients need to stay in intensive care units. It could also significantly reduce the strain on hospital beds."

The study is being managed by staff from the Clinical Research Support Centre in the Belfast Health and Social Care Trust and has been supported by the infrastructure provided by the Northern Ireland Clinical Research Network. The Clinical Research Facility at NUI Galway is providing additional support. The study is taking place over four years in approximately 25 other intensive care units throughout the UK and Ireland.


'/>"/>

Contact: Donna McCullough
comms.office@qub.ac.uk
44-289-097-5391
Queen's University Belfast
Source:Eurekalert

Related biology news :

1. Unlike us, honeybees naturally make quick switch in their biological clocks, says Hebrew University researcher
2. University of Utah microbubbles clean dirty soil in China
3. Ben-Gurion University of the Negev hosts UNESCO conference on drylands, deserts and desertification
4. Brown University chemists simplify biodiesel conversion
5. New fisheries system will save about $20 million, Iowa State University researchers find
6. Hebrew University research holds promise for development of new osteoporosis drug
7. Auxogyn licenses noninvasive embryo assessment technology from Stanford University
8. Iowa State University researcher examines mosquito gene for new disease response
9. WSJ honors university-created LLC with Innovation Award
10. University of Nevada, Reno, demonstrates successful sludge-to-power research
11. University of Nevada, Reno demonstrates successful sludge-to-power research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology: